News & Blog

Author Archives: Tom Halkin

Glossary Blog, June 2018: Pivotal Clinical Trial

Pivotal Clinical Trial: A clinical trial or study intended to provide evidence for a new treatment approval by the United States Food & Drug Administration (FDA) This month we take a quick look at term that’s used in the field of biomedical research and drug development, that has both a figurative and an official technical/literal […]

Brain Tumor Facts & Figures, June 2018: Annual Report to the Nation on the Status of Cancer

Our monthly series called “Brain Tumor Facts & Figures” will provide information and data that can help you in your advocacy, fundraising, and awareness-raising efforts by presenting statistics that can help convey the difficult realities our community is up against. These can be used to make a case for support to your members of Congress, […]

Potential Brain Tumor Treatments Entering the Pivotal Phase of Evaluation – June 2018

A large, randomized, controlled Phase III clinical trial is traditionally the last, pivotal step in the evaluation of a potential new medicine before it is approved for use by all patients with the indicated disease. A year ago, the NBTS staff conducted and published a review of all the Phase III clinical trials for glioblastoma […]

Share